Show
Sort by
-
- Conference Paper
- C3
- open access
Drug response profiling informs personalized bridging to cell therapy for patients with relapsed/refractory acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
The prognostic value of IKZF1(plus) in B‐cell progenitor acute lymphoblastic leukemia : results from the EORTC 58951 trial
-
- Journal Article
- A1
- open access
CircRNAs dysregulated in juvenile myelomonocytic leukemia : CircMCTP1 stands out
-
- Journal Article
- A1
- open access
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
-
- Journal Article
- A1
- open access
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
-
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation : results of EORTC Children Leukemia Group study 58951
-
Pediatric randomized trial EORTC CLG 58951 : outcome for adolescent population with acute lymphoblastic leukemia
-
- Conference Paper
- C3
- open access
NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia : a good prognostic subtype identified in a collaborative international study
-
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)
-
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia